Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a major challenge facing the world. Certain guidelines issued by National Health Commission of the People's Repubilic of China recommend intravenous immunoglobulin (IVIG) for adjuvant treatment of COVID-19. However, there is a lack of clinical e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xiao, Tian, Li, Zhou, Lei, Jia, Xinhua, Kong, Li, Xue, Yitao, Hao, Hao, Meng, Xianqing, Zhang, Feihu, Dong, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139546/
https://www.ncbi.nlm.nih.gov/pubmed/34020680
http://dx.doi.org/10.1186/s12985-021-01575-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139546/
https://www.ncbi.nlm.nih.gov/pubmed/34020680
http://dx.doi.org/10.1186/s12985-021-01575-3

Ejemplares similares